4.7 Article

Sarcomatoid Renal Cell Carcinoma: A Comprehensive Review of the Biology and Current Treatment Strategies

期刊

ONCOLOGIST
卷 17, 期 1, 页码 46-54

出版社

WILEY
DOI: 10.1634/theoncologist.2011-0227

关键词

Sarcomatoid; Renal cell carcinoma; Kidney cancer

类别

资金

  1. GlaxoSmithKline
  2. NIH, National Cancer Institute, Center for Cancer Research
  3. NATIONAL CANCER INSTITUTE [Z01BC011028, Z01BC011023, ZIDBC011089, ZIABC011038, ZIABC011043, Z01BC011089, ZIABC011028] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Recent advancements in the molecular characterization of renal cell carcinoma altered the classification system and now kidney cancer is divided into several distinct histologic subtypes. Although once a separate histologic category, sarcomatoid renal cell carcinoma is no longer considered a separate tumor type because it can occur with all histologic subtypes. Limited research on tumors with sarcomatoid change has led to minimal progress in the understanding and treatment of these tumors. Because the sarcomatoid variant of renal cell carcinoma can account for approximately one in six cases of advanced kidney cancer, we hope to familiarize clinicians with these tumors by describing the historic background, histologic features, molecular characterization, diagnosis, prognosis, treatment strategies, and active clinical trials of this aggressive type of tumor. The Oncologist 2012; 17: 46-54

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据